Westbrook, T. C., Cackowski, F. C., Alumkal, J. J., Kumaraswamy, A., Caram, M. V., Yentz, S. E., Vaishampayan, U. N., Pai, M., Braun, T., Reichert, Z. R. (2025). Study of JAK inhibition in stem-like prostate cancer (JASPER): A phase 1/2 multicenter study of ruxolitinib and enzalutamide in castration resistant prostate cancer undergoing lineage plasticity.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.5_suppl.tps297